Mushrooms, Inc. Announces Name and Ticker Symbol Change on OTC Markets to “MSRM”
ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) — Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly…
ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) — Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly…
ESTERO, Fla., Nov. 29, 2022 (GLOBE NEWSWIRE) — Mushrooms Inc. (OTC: MSRM) (the “Company”), formerly…
New York, NY, and Tel Aviv, ISRAEL, Nov. 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
New York, NY, and Tel Aviv, ISRAEL, Nov. 29, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — Todos Medical,…
New clinical data to be presented from the Company’s phase 2 clinical trial of CAN-2409…
New clinical data to be presented from the Company’s phase 2 clinical trial of CAN-2409…
New collaboration builds on encouraging clinical data previously reported from INSIGHT-004 in multiple solid tumour…
New collaboration builds on encouraging clinical data previously reported from INSIGHT-004 in multiple solid tumour…
INmune Bio, a leader in novel therapies and innovative trial design for AD participates in 15th CTAD…
INmune Bio, a leader in novel therapies and innovative trial design for AD participates in 15th CTAD…
Former Roche executive Amy Levin, RAC, brings more than 20 years of regulatory affairs experience…
Former Roche executive Amy Levin, RAC, brings more than 20 years of regulatory affairs experience…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Nov. 29, 2022 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation…
Peer-reviewed data indicates that food significantly decreases and delays the absorption of diazepam dosed via…
Peer-reviewed data indicates that food significantly decreases and delays the absorption of diazepam dosed via…
Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia Lugano,…
Helsinn announces presentation on CINV trial at European Society for Medical Oncology (ESMO) Asia Lugano,…
Tel-Aviv, Nov. 29, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical…
Tel-Aviv, Nov. 29, 2022 (GLOBE NEWSWIRE) — SciSparc Ltd. (Nasdaq: SPRC), a specialty, clinical-stage pharmaceutical…